GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NDatalyze Corp (OTCPK:NDATF) » Definitions » EBITDA Margin %

NDatalyze (NDatalyze) EBITDA Margin % : -425.00% (As of Nov. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NDatalyze EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. NDatalyze's EBITDA for the three months ended in Nov. 2023 was $-0.12 Mil. NDatalyze's Revenue for the three months ended in Nov. 2023 was $0.03 Mil. Therefore, NDatalyze's EBITDA margin for the quarter that ended in Nov. 2023 was -425.00%.


NDatalyze EBITDA Margin % Historical Data

The historical data trend for NDatalyze's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDatalyze EBITDA Margin % Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23
EBITDA Margin %
-156.10 -5.00 -104.02 -274.85 -718.90

NDatalyze Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -596.43 -1,314.29 -380.00 429.63 -425.00

Competitive Comparison of NDatalyze's EBITDA Margin %

For the Health Information Services subindustry, NDatalyze's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NDatalyze's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where NDatalyze's EBITDA Margin % falls into.



NDatalyze EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

NDatalyze's EBITDA Margin % for the fiscal year that ended in Feb. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Feb. 2023 )/Revenue (A: Feb. 2023 )
=-0.913/0.127
=-718.90 %

NDatalyze's EBITDA Margin % for the quarter that ended in Nov. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Nov. 2023 )/Revenue (Q: Nov. 2023 )
=-0.119/0.028
=-425.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NDatalyze  (OTCPK:NDATF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


NDatalyze EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of NDatalyze's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


NDatalyze (NDatalyze) Business Description

Traded in Other Exchanges
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.

NDatalyze (NDatalyze) Headlines

From GuruFocus